Do splanchnic viscera contribute to liver preservation reperfusion injury?

Transplantation

Volumn 61, Issue 8, 1996, Pages 1142-1147

  Sankary, Howard N ^a   Foster, Preston ^a   Brown, Esther ^a   Williams, James ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOSTIMULATION; KUPFFER CELL; LIVER PRESERVATION; LIVER TRANSPLANTATION; MALE; NONHUMAN; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; REVASCULARIZATION; SPLANCHNIC BLOOD FLOW; TISSUE DISTRIBUTION;

ANIMALS; DISEASE MODELS, ANIMAL; LIVER; LIVER TRANSPLANTATION; MALE; RATS; RATS, INBRED LEW; REPERFUSION INJURY; SPLANCHNIC CIRCULATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030007824     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199604270-00003     Document Type: Article

References (32)

1. Kalayogu M, Sollinger H, Stratta R, et al. Extended preservation of the liver for clinical transplantation. Lancet 1988; 2: 617.
2. Fox LE, Marsh DC, Southard JH, Belzer FO. The effect of pH on the viability of hypothermically stored rat hepatocytes. Cryobiology 1989; 26: 186.
3. Marsh DC, Lindell SL, Fox LE, Belzer FO, Southard JH. Hypothermic preservation of hepatocytes. I. Role of cell swelling. Cryobiology 1989; 26: 524.
4. Ikeda T, Yanaga K, Kishikawa K, Kakizoe S, Shimada M, Sugimachi K. Ischemic injury in liver transplantation: difference in injury sites between warm and cold ischemia in rats. Hepatology 1992; 16: 454.
5. Marzi I, Zhong Z, Lemasters JJ, Thurman RG. Evidence that graft survival is not related to parenchymal cell viability in rat liver transplantation The importance of nonparenchymal cells. Transplantation 1989; 48: 463.
6. Caldwell-Kenkel JC, Currin RT, Tanaka Y, Thurman RG, Lemasters JJ. Reperfusion injury to endothelial cells following cold ischemic storage of rat livers. Hepatology 1989; 10: 292.
7. Takei Y, Marzi I, Kauffman FC, Currin RT, Lemasters JJ, Thurman RG. Increase in survival time of liver transplants by protease inhibitors and a calcium channel blocker, nisoldipine. Transplantation 1990; 50: 14.
8. Takei Y, Marzi I, Kauffman FC, Cowper K, Lemasters JJ, Thurman RG. Prevention of early graft failure by the calcium channel blocker nisoldipine: involvement of Kupffer cells. Transplant Proc 1990; 22: 2202.
9. Caldwell-Kenkel JC, Currin RT, Tanaka Y, Thurman RG, Lemasters JJ. Kupffer cell activation and endothelial cell damage after storage of rat livers: effects of reperfusion. Hepatology 1991; 13: 83.
10. Marzi I, Cowper K, Takei Y, Lindert K, Lemasters JJ, Thurman RG. Methyl palmitate prevents Kupffer cell activation and improves survival after orthotopic liver transplantation in the rat. Transplant Int 1991; 4: 215.
11. Steininger R, Roth E, Fugger R, et al. Transhepatic metabolism of TNF-alpha, IL-6, and endotoxin in the early hepatic reperfusion period after human liver transplantation. Transplantation 1994; 58: 179.
12. Arii S, Monden K, Adachi Y, et al. Pathogenic role of Kupffer cell activation in the reperfusion injury of cold-preserved liver. Transplantation 1994; 58: 1072.
13. Currin RT, Reinstein LJ, Lichtman SN, Thurman RG, Lemasters JJ. Inhibition of tumor necrosis factor release from cultured rat Kupffer cells by agents that reduce graft failure from storage injury. Transplant Proc 1993; 25: 1631.
14. Chazouilleres O, Guechot J, Balladur P, et al. Tumor necrosis factor-alpha in liver transplantation and resection: no evidence for a key role in ischemia-reperfusion injury. J Hepatol 1992; 16: 376.
15. Andus T, Holstege A. Cytokines and the liver in health and disease: effects on liver metabolism and fibrogenesis. Acta Gastroenterol Belg 1994; 57: 236.
16. Badger IL, Townsend P, Buckels JA. Tumour necrosis factor alpha secretion in leporine endotoxaemia: role of the liver and effects of hepatic ischaemia. Gut 1992; 33: 694.
17. Kimura RE, LaPine T, Gooh W. Portal venous and aortic glucose and lactate changes in a chronically catheterized rat. Pediatr Res 1993; 23: 235.
18. Remick D, Strieter R, Lynch J, Nugyer D. In vivo dynamics of murine tumor necrosis factor α gene expression. Lab Invest 1989; 60: 776.
19. Sankary HN, Foster P, Brown E, Hart M, Williams JW. A comparison of Collins and UW solutions for cold ischemic preservation of the rat liver. J Surg Res 1991; 51: 87.
20. Sankary H, Foster P, Brown E, Bone R. Inhibition of Kupffer cell activity with latex particle pre-treatment results in improvement in hepatic allograft viability after prolonged periods of cold storage. Surg Forum 1990; 41: 413.
21. Castaing D, Beaubernard C, Ariogul O, Gigou M, Franco D, Bismuth H. Liver atrophy and encephalopathy after portacaval shunt in the rat. Eur Surg Res 1982; 14: 192.
22. Ogle CK, Wu JZ, Mao X, Szczur K, Alexander JW, Ogle JD. Heterogeneity of Kupffer cells and splenic, alveolar, and peritoneal macrophages for the production of TNF, IL-1, and IL-6. Inflammation 1994; 18: 511.
23. Hamilton G, Prettenhofer M, Zommer A, et al. Intraoperative course and prognostic significance of endotoxin, tumor necrosis factor-alpha and interleukin-6 in liver transplant recipients. Immunobiology 1991; 182: 425.
24. Scott-Conner CE, Grogan JB. The pathophysiology of biliary obstruction and its effect on phagocytic and immune function. J Surg Res 1994; 57: 316.
25. Jiang J, Bahrami S, Leichtfried G, Heinz R, Ohlinger W, Schlag G. Kinetics of endotoxin and tumor necrosis factor appearance in portal and systemic circulation after hemorrhagic shock in rats. Ann Surg 1995; 221: 100.
26. Byerley LO, Alcock NW, Starnes HF Jr. Sepsis-induced cascade of cytokine mRNA expression: correlation with metabolic changes. Am J Physiol 1992; 262: E728.
27. Doherty GM, Jensen JC, Buresh CM, Norton JA. Hormonal regulation of inflammatory cell cytokine transcript and bioactivity production in response to endotoxin. Cytokine 1992; 4: 55.
28. Gao W, Lemasters JJ, Thurman RG. Development of a new method for hepatic rearterialization in rat orthotopic liver transplantation: reduction of liver injury, and improvement of surgical outcome by arterialization. Transplantation 1993; 56: 19.
29. Palombo JD, Burke PA, Moldawer LL, Forse RA, Lewis WD, Jenkins RL. Assessment of the cytokine response in liver donors at the time of organ procurement and association with allograft function after orthotopic transplantation. J Am Coll Surg 1994; 179: 209.
30. Scoazec JY, Durand F, Degott C, et al. Expression of cytokine-dependent adhesion molecules in postreperfusion biopsy specimens of liver allografts. Gastroenterology 1994; 107: 1094.
31. Hoffmann MW, Wonigeit K, Steinhoff G, et al. Production of cytokines (TNF-alpha, IL-1-beta) and endothelial cell activation in human liver allograft rejection. Transplantation 1993; 55: 329.
32. Carles J, Fawaz R, Neaud V, et al. Ultrastructure of human liver grafts preserved with UW solution: comparison between patients with low and high postoperative transaminases levels. J Submicrosc Cytol Pathol 1994; 26: 67.